ECM
WST icon

Element Capital Management’s West Pharmaceutical WST Stock Holding History

Element Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,445
Closed -$1.29M – 215
2023
Q3 		$1.29M Sell
3,445
-4,799
-58% -$1.86M 0.11% 183
2023
Q2 		$3.15M Buy
8,244
+483
+6% +$173K 0.21% 123
2023
Q1 		$2.69M Buy
+7,761
New +$2.27M 0.2% 104
2019
Q2 		– Sell
-8,175
Closed -$901K – 746
2019
Q1 		$901K Buy
+8,175
New +$850K 0.03% 384

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Element Capital Management's WST Position: Q4 2023 in Review

Element Capital Management sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 3,445 shares — an estimated $1.29M sold.

Element Capital Management first reported a position in WST in Q1 2019 and held it in 4 quarters. The position peaked at $3.15M in Q2 2023. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Element Capital Management reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 3,445 West Pharmaceutical shares in Q4 2023, an estimated $1.29M.
  • Element Capital Management first reported a position in West Pharmaceutical in Q1 2019 and held it in 4 quarters.
  • Element Capital Management's West Pharmaceutical position peaked at $3.15M in Q2 2023.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.